Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons
- PMID: 15067721
- DOI: 10.1002/cne.20098
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons
Abstract
The dopaminergic neurons in the ventral substantia nigra (SN) are significantly more vulnerable to degeneration in Parkinson's disease (PD) than the dopaminergic neurons in the ventral tegmental area (VTA). The ventral SN neurons also contain significantly more neuromelanin pigment than the dopaminergic neurons in the VTA. In vitro data indicate that neuromelanin pigment is formed from the excess cytosolic catecholamine that is not accumulated into synaptic vesicles by the vesicular monoamine transporter-2 (VMAT2). By using quantitative immunohistochemical methods in human postmortem brain, we sought to examine the relative contents of VMAT2 within neurons that contain different amounts of neuromelanin pigment. The immunostaining intensity (ISI) was measured for VMAT2 and also for the rate-limiting enzyme for the synthesis of dopamine, tyrosine hydroxylase (TH). ISI measures were taken from the ventral SN region where neurons are most vulnerable to degeneration in PD, nigrosome-1 (N1); from the ventral SN region where cells are moderately vulnerable to degeneration in PD, the matrix (M); and from VTA neurons near the exit of the third nerve (subregion III). The data indicate that 1) subregion III neurons have significantly higher levels of VMAT2 ISI compared with N1 neurons (more than twofold) and M neurons (45%); 2) there is an inverse relationship between VMAT2 ISI and neuromelanin pigment in the N1 and III neurons; 3) there is an inverse relationship between VMAT2 ISI and the vulnerability to degeneration in PD in the N1, M, and III subregions; and 4) neurons with high VMAT2 ISI also have high TH ISI. These data support the hypothesis that midbrain dopaminergic neurons that synthesize greater amounts of dopamine have more vesicular storage capacity for action potential-induced release of transmitter and that the ventral SN neurons accumulate the most neuromelanin pigment, in part because they have the least VMAT2 protein.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.J Comp Neurol. 2004 Nov 8;479(2):198-215. doi: 10.1002/cne.20323. J Comp Neurol. 2004. PMID: 15452855
-
Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.Synapse. 2002 Aug;45(2):113-24. doi: 10.1002/syn.10092. Synapse. 2002. PMID: 12112404
-
The protective effect of vitamin E on locus coeruleus in early model of Parkinson's disease in rat: immunoreactivity evidence.Iran Biomed J. 2008 Oct;12(4):217-22. Iran Biomed J. 2008. PMID: 19079535
-
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.Prog Neurobiol. 2005 Feb;75(2):109-24. doi: 10.1016/j.pneurobio.2005.02.001. Prog Neurobiol. 2005. PMID: 15784302 Review.
-
Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.Anat Rec. 2002 Jun 1;267(2):87-93. doi: 10.1002/ar.10089. Anat Rec. 2002. PMID: 11997877 Review.
Cited by
-
In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease.Brain. 2023 Mar 1;146(3):1040-1052. doi: 10.1093/brain/awac445. Brain. 2023. PMID: 36717986 Free PMC article.
-
Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities.Ann Clin Transl Neurol. 2019 Jan 8;6(2):406-415. doi: 10.1002/acn3.707. eCollection 2019 Feb. Ann Clin Transl Neurol. 2019. PMID: 30847375 Free PMC article. Review.
-
Neuromelanin of the human substantia nigra: an update.Neurotox Res. 2014 Jan;25(1):13-23. doi: 10.1007/s12640-013-9435-y. Epub 2013 Oct 24. Neurotox Res. 2014. PMID: 24155156 Review.
-
Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.PLoS One. 2016 Mar 8;11(3):e0151191. doi: 10.1371/journal.pone.0151191. eCollection 2016. PLoS One. 2016. PMID: 26954690 Free PMC article.
-
Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson.NPJ Parkinsons Dis. 2023 Jun 15;9(1):89. doi: 10.1038/s41531-023-00514-z. NPJ Parkinsons Dis. 2023. PMID: 37322038 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources